Purchase Order HHSN272201400326P
Award Date 2/24/14
Potential Completion Date 3/26/14
Potential Value $5.7K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Irvine, CA 92618, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Immport Therapeutics Inc., doing business as Antigen Discovery Inc. The contract, valued at $15,000.00, is for the provision of falciparum custom protein microarrays. Immport Therapeutics is a biotechnology company that specializes in high-throughput protein microarray technology and related services, and has...
- This is a $300,000.00 firm fixed price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Immport Therapeutics Inc., doing business as Antigen Discovery Inc. The contract is for SBIR 133 - ANTIGEN and has an ultimate completion date of September 9, 2025. Immport Therapeutics is a biotechnology company that specializes in protein microarray technology and related services to support infectious disease detection, monitoring, and research....
- This is a firm fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Immport Therapeutics Inc., doing business as Antigen Discovery Inc., for $30,000.00. The contract is for the provision of microarray products and services to support detection and response efforts related to pathogens such as monkeypox virus, Brucella, SARS-CoV-2, and Leptospirosis. Immport Therapeutics is a biotechnology company specializing in high throughput...
- This SBIR Phase I contract was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Immport Therapeutics, Inc., doing business as Antigen Discovery Inc. The $150,000.00 firm fixed price purchase order is for the company's high throughput protein microarray technology and related services. Immport Therapeutics has provided these products and services to support the CDC's detection and response efforts for pathogens such as monkeypox virus, Brucella,...
- This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Geneimmune Biotechnology Corp, a small, Asian-Pacific American-owned biotechnology company based in Rockville, Maryland. The contract, valued at $98,958.95, is for the provision of various research and development services related to genetics, immunology, virology, and infectious diseases, including...
- The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, awarded a $49,946.10 firm-fixed-price purchase order contract for antibody expression services to Biointron Biological USA Inc., a small disadvantaged business. The contract, which has no set-aside designation, has an ultimate completion date of July 11, 2025. The award was made on July 12, 2024. NIAID is responsible for conducting and supporting research to understand, treat, and prevent infectious and...
- The Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $16,345.50 purchase order to Biointron Biological USA Inc. for antibody expression services. As a firm fixed price contract, Biointron will provide the requested antibody expression services to NIH/NIAID at Metuchen, New Jersey from September 19, 2023 through December 29, 2023. No subcontractors or set aside designations were indicated. NIAID conducts and...
- This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to Irepertoire Inc., a self-certified small disadvantaged business. The $6,580 firm-fixed-price purchase order is for IPAIR Collaboration and Data Analysis Services, which likely involve T-cell receptor sequencing, RNA sequencing, PCR amplification, and related laboratory testing to support NIAID's research and...
- <p>This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Affymetrix, Inc. for the delivery of antibodies. The contract has a ceiling value of $7,771.50 and a completion date of August 28, 2015. The contract was not set aside for any specific business type. As a manufacturer of goods, Affymetrix, Inc. is the prime contractor for this award.</p>
- This firm fixed price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to Geneimmune Biotechnology Corp., a biotechnology company based in Rockville, Maryland. The $31,435.00 contract is for the production of 20 liters of monoclonal antibodies at $1,500 per liter. This award supports NIAID's infectious disease research efforts, leveraging Geneimmune's expertise in areas such as gene...